J. Tervaert

C. Kallenberg, P. van Paassen, A. Voskuyl, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?

P. Heeringa, J. Tervaert, 2003, The Netherlands journal of medicine.

Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels

M. Daemen, J. C. Cohen Tervaert, E. Biessen, 2010, Thrombosis and Haemostasis.

Infectious Serologies and Autoantibodies in Hepatitis C and Autoimmune Disease-Associated Mixed Cryoglobulinemia

Y. Shoenfeld, S. Bombardieri, N. Agmon-Levin, 2012, Clinical Reviews in Allergy & Immunology.

Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans.

K. Clément, E. Blaak, G. Goossens, 2012, Molecular immunology.

Monocyte activation in patients with Wegener’s granulomatosis

C. Kallenberg, J. Tervaert, A. Kobold, 1999, Annals of the rheumatic diseases.

Neutrophils and T cells: bidirectional effects and functional interferences.

J. Damoiseaux, J. Tervaert, M. Thewissen, 2011, Molecular immunology.

Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study.

T. Links, C. Stegeman, J. Tervaert, 2005, Arthritis and rheumatism.

ANCA-GBM Dot-Blot: Evaluation of an Assay in the Differential Diagnosis of Patients Presenting with Rapidly Progressive Glomerulonephritis

P. Limburg, J. Damoiseaux, C. Roozendaal, 2004, Journal of Clinical Immunology.

ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease.

P. Heeringa, J. Damoiseaux, J. Tervaert, 2003, European journal of internal medicine.

Laboratory assessment in musculoskeletal disorders.

P. van Paassen, J. Damoiseaux, J. Tervaert, 2003, Best practice & research. Clinical rheumatology.

Chapter 5 Native and recombinant proteins to analyze autoantibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis

C. Kallenberg, P. Limburg, C. Stegeman, 2017 .

Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

C. Kallenberg, J. Savige, D. Blockmans, 2017, Nature Reviews Rheumatology.

University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt,

C. Kallenberg, J. Savige, D. Blockmans, 2017 .

EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis.

P. van Paassen, J. Damoiseaux, J. Tervaert, 2009, Journal of immunological methods.

Systemic vasculitides, an introduction

C. Kallenberg, J. Tervaert, 2001 .

Disease-modifying Therapy in Vasculitides

C. Kallenberg, J. Tervaert, 2012, Progress in Inflammation Research.

Is Wegener's granulomatosis an autoimmune disease?

C. Kallenberg, C. Savage, C. Kallenberg, 2000, Current opinion in rheumatology.

What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.

C. Kallenberg, J. Tervaert, 1999, Current opinion in nephrology and hypertension.

Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.

P. Merkel, Hyon K. Choi, J. Tervaert, 1999, Arthritis and rheumatism.

Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.

C. Kallenberg, P. Limburg, T. The, 1991, The American journal of medicine.

Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.

C. Kallenberg, C. Kallenberg, C. Stegeman, 1993, Annals of the rheumatic diseases.

Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells.

J. Damoiseaux, J. Tervaert, P. J. Van Breda Vriesman, 2002, Journal of autoimmunity.

Hypertension: an autoimmune disease?

J. Tervaert, 2011, Hypertension Research.

TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.

P. Heeringa, J. Tervaert, D. Huugen, 2006, Clinical journal of the American Society of Nephrology : CJASN.

CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients

I. Bernard, A. Saoudi, J. Damoiseaux, 2009, PloS one.

Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment

C. Kallenberg, C. Stegeman, J. Tervaert, 2001 .

Prevalence of rubella serum antibody in autoimmune diseases.

Y. Shoenfeld, A. Altman, S. Bombardieri, 2012, Revista brasileira de reumatologia.

Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators

P. Menheere, J. Damoiseaux, J. Smolders, 2013, Journal of Neuroimmunology.

2020 international consensus on ANCA testing beyond systemic vasculitis.

S. Vermeire, Y. Shoenfeld, M. Ferrante, 2020, Autoimmunity reviews.

43 - Infections and Vasculitis

C. Stegeman, J. Tervaert, 2004 .

In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.

P. Limburg, E. Popa, C. Franssen, 2002, Arthritis and rheumatism.

Anti-Neutrophil Cytoplasmic Antibodies (ANCA): New Tools in the Diagnosis and Follow-Up of Necrotizing Glomerulonephritis and Vasculitis

C. Kallenberg, J. Tervaert, 1991 .

CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis

A. Kroon, P. D. de Leeuw, J. Damoiseaux, 2017, Rheumatology International.

Prevalence of Anticardiolipin Antibodies in Patient Cohorts with Distinct Clinical Manifestations of the Antiphospholipid Syndrome

H. ten Cate, L. Peeters, J. Damoiseaux, 2009, Annals of the New York Academy of Sciences.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group

A. Vaglio, G. Emmi, C. Salvarani, 2019, Internal and Emergency Medicine.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

P. van Paassen, V. Tesar, C. Savage, 2010, The New England journal of medicine.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

P. van Paassen, V. Tesar, C. Savage, 2015, Annals of the rheumatic diseases.

Clinical immunology--autoimmunity in the Netherlands.

C. Kallenberg, J. Tervaert, 2014, Immunology letters.

Autoantibodies and Vascular Inflammation

C. Kallenberg, J. Tervaert, J. Sanders, 2012 .

Rituximab in ANCA-associated vasculitis: a revolution?

J. Tervaert, 2011 .

The definition of autoimmune disease: are Koch's postulates applicable?

J. Damoiseaux, J. Tervaert, 2002, The Netherlands journal of medicine.

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.

P. Menheere, J. Damoiseaux, J. Smolders, 2009, Autoimmunity reviews.

Chapter 2 HLA-DR 4 , DR 13 ( 6 ) and the ancestral haplotype A 1 B 8 DR 3 are associated with ANCA-associated vasculitis

P. Stassen, J. Tervaert, B. Hepkema, 2018 .

Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate

D. Jayne, J. Tervaert, N. Rasmussen, 2017, Rheumatology.

The Renaissance of Antineutrophil Cytoplasmic Antibodies as a Predictor of Relapse: Ippon for Japan

J. Tervaert, 2015, The Journal of Rheumatology.

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.

J. Damoiseaux, A. Duijvestijn, J. Tervaert, 2009, Autoimmunity reviews.

Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Antibodies for Inflammatory Bowel Disease: High Prevalence in Patients with Celiac Disease

J. Damoiseaux, C. Roozendaal, M. Russel, 2004, Journal of Clinical Immunology.

Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis.

L. Beckers, M. Daemen, P. Heeringa, 2005, Atherosclerosis.

ASIA (Shoenfeld's syndrome) due to hysteroscopic Essure sterilization.

J. Tervaert, Utkarsh Chauhan, B. Cassidy, 2021, Autoimmunity reviews.

The relation between Staphylococcus aureus and Wegener's granulomatosis: current knowledge and future directions.

E. Popa, J. Tervaert, Eliane R. Popa, 2003, Internal medicine.

Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

J. Damoiseaux, J. Smolders, R. Hupperts, 2011, Multiple sclerosis.

Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission

P. Menheere, J. Damoiseaux, J. Smolders, 2011, Journal of Neuroimmunology.

Pneumococcal vaccination does not increase circulating levels of IgM antibodies to oxidized LDL in humans and therefore precludes an anti-atherogenic effect.

J. Damoiseaux, J. Tervaert, G. Rijkers, 2007, Atherosclerosis.

The Prevalence of Self-Reported Health Complaints and Health-Related Quality of Life in Women With Breast Implants

R. R. van der Hulst, J. Tervaert, M. Colaris, 2020, Aesthetic surgery journal.

Cardiovascular, Pulmonary and Renal Pathology Myeloperoxidase Is Critically Involved in the Induction of Organ Damage after Renal Ischemia Reperfusion

M. Daha, P. Heeringa, W. Buurman, 2007 .

In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, C. Franssen, 1999, Journal of the American Society of Nephrology : JASN.

Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

P. Vermeersch, D. Blockmans, X. Bossuyt, 2017, Clinical chemistry and laboratory medicine.

Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders

P. Limburg, E. Brouwer, C. Kallenberg, 1991, Clinical and experimental immunology.

Autoantibody Standardization in the Netherlands

C. Kallenberg, P. Limburg, H. Hooijkaas, 2009, Annals of the New York Academy of Sciences.

Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et al.

C. Stegeman, J. Tervaert, M. Boomsma, 1999, Arthritis and rheumatism.

1 ANCA Diagnostics in Clinical Practice : New Developments

J. Tervaert, J. Austen, 2012 .

ANCA Diagnostics in Clinical Practice: New Developments

J. Damoiseaux, J. Tervaert, J. Austen, 2011 .

Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

C. Kallenberg, P. Heeringa, E. Brouwer, 1998, Kidney international.

Pulmonary Manifestations of Systemic Vasculitides

C. Kallenberg, W. Timens, C. Stegeman, 1998 .

Chapter 48 – Autoimmunity – Vasculitis

J. Damoiseaux, J. Tervaert, 2005 .

Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models

P. Heeringa, J. Tervaert, D. Huugen, 2004, Current opinion in rheumatology.

The role of superantigens in vasculitis.

E. Popa, N. Bos, J. Tervaert, 1999, Current opinion in rheumatology.

Pathophysiological mechanisms in anti-myeloperoxidase-associated vasculitis

J. Tervaert, 2000 .

Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.

P. Limburg, J. Kleibeuker, H. Peter, 1998, The American journal of medicine.

Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis.

M. Sokolowska, K. Savelkouls, J. Damoiseaux, 2008, Clinical immunology.

The IgM Response to Modified LDL in Experimental Atherosclerosis

P. Heeringa, J. Damoiseaux, M. Gijbels, 2009, Annals of the New York Academy of Sciences.

Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?

P. Heeringa, J. Tervaert, D. Huugen, 2005, Trends in immunology.

CONTEMPORARY CHALLENGES IN AUTOIMMUNITY

P. Heeringa, J. Damoiseaux, M. Gijbels, 2009 .

Antimyeloperoxidase antibodies in the Churg-Strauss syndrome

R. Goldschmeding, J. Tervaert, J. Elema, 1991, Thorax.

Leptin and ANCA-associated vasculitis: a healthy link?

J. Tervaert, M. Thewissen, 2007, Rheumatology.

Wegener's Granulomatosis

J. Tervaert, M. Slot, 2004, Autoimmunity.

Are Antineutrophil Cytoplasmic Antibodies Pathogenic in Wegener’s Granulomatosis? Lessons From In Vitro and In Vivo Experimental Findings

P. Heeringa, C. Kallenberg, J. Tervaert, 1999 .

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

P. Limburg, H. Bootsma, P. Spronk, 1996, British journal of rheumatology.

Antimyeloperoxidase-associated Proliferative Glomerulonephritis: An Animal Model By Elisabeth Brouwer,* Minke G. Huitema,* Pieter A. Klok,~

C. Kallenberg, J. Weening, J. Tervaert, 1993 .

Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

C. Kallenberg, C. Kallenberg, J. Tervaert, 1992, The American journal of medicine.

An unusual case of ANCA positive disease

S. van der Linden, J. Tervaert, A. Boonen, 2003, Annals of the rheumatic diseases.

Cell adhesion molecules in vasculitis.

C. Kallenberg, J. Tervaert, Jan Willem Cohen Tervaert, 1997, Current opinion in rheumatology.

Standard therapeutic regimens for vasculitis

C. Kallenberg, C. Stegeman, J. Tervaert, 2001 .

Anti-myeloperoxidase antibodies in Churg-Strauss syndrome

C. Kallenberg, J. Tervaert, Cornelis Kallenberg, 1993, Journal of Neurology.

Neurologic manifestations of systemic vasculitides.

C. Kallenberg, J. Tervaert, 1993, Rheumatic diseases clinics of North America.

Chapter 4 Image analysis ; a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener ’ s Granulomatosis

C. Kallenberg, J. Damoiseaux, M. Patnaik, 2018 .

Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.

J. Damoiseaux, J. Tervaert, C. Dähnrich, 2012, Journal of immunological methods.

Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

P. van Paassen, P. Heeringa, J. Tervaert, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.

M. Harmsen, W. V. van Son, T. The, 2000, Kidney international.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

V. Tesar, P. Bacon, C. Pusey, 2003, The New England journal of medicine.

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

P. Limburg, J. Hermans, C. Kallenberg, 2000, Arthritis and rheumatism.

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis

M. Haubitz, X. Puéchal, D. Jayne, 2017, Annals of the rheumatic diseases.

Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis

C. Kallenberg, W. Sluiter, J. Tervaert, 1994, Annals of Internal Medicine.

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse

P. Menheere, J. Damoiseaux, J. Smolders, 2011, Journal of Neuroimmunology.

Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, P. D. de Jong, 1998, Journal of the American Society of Nephrology : JASN.

Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

C. Kallenberg, A. Fauci, J. Velosa, 1989, Archives of internal medicine.

From ANA to ENA: how to proceed?

J. C. Cohen Tervaert, J. Damoiseaux, J. Tervaert, 2006, Autoimmunity reviews.

A difficult diagnosis

C. Stegeman, J. Tervaert, 2004, The Lancet.

Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature

R. R. van der Hulst, J. Tervaert, M. Colaris, 2017, Clinical Rheumatology.

Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

C. Kallenberg, C. Kallenberg, J. Tervaert, 2001, Rheumatic diseases clinics of North America.

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis

P. Menheere, J. Damoiseaux, J. Smolders, 2009, Journal of Neuroimmunology.

An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detection.

R. van Wijk, A. V. D. Van Der Zee, G. Molema, 2001, Clinical and experimental rheumatology.

Effects of vitamin D on the peripheral adaptive immune system: a review.

J. Damoiseaux, J. Smolders, R. Hupperts, 2011, Autoimmunity reviews.

Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies.

J. Tervaert, C. Belizna, Cristina Belizna, 1997, Seminars in arthritis and rheumatism.

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

R. Toes, T. V. van Berkel, J. Kuiper, 2010, Cardiovascular research.

Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

C. Kallenberg, J. Tervaert, J. Broekroelofs, 1994, Digestive diseases and sciences.

CD3 directed bispecific antibodies induce increased lymphocyte–endothelial cell interactions in vitro

B. Kroesen, G. Molema, D. Meijer, 2000, British Journal of Cancer.

Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.

J. Tervaert, 2009, Clinical and experimental immunology.

Abstract 1350: OxLDL-Pulsed Dendritic Cells: An Immunotherapy in Atherosclerosis

R. Toes, J. Kuiper, P. Vos, 2006 .

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.

H. Hartung, B. Hemmer, C. Marra, 2007, Archives of neurology.

Leukocyte Cell Adhesion Molecules in Vasculitis

C. Kallenberg, J. Tervaert, 2001 .

Immunomodulation with OCH-pulsed dendritic cells attenuates atherosclerosis

H. Overkleeft, R. Toes, G. A. Marel, 2007 .

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023.

Y. Shoenfeld, H. Amital, J. Tervaert, 2023, Autoimmunity reviews.

Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica.

R. van Wijk, P. Limburg, C. Kallenberg, 1993, Advances in experimental medicine and biology.

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.

D. Salant, P. van Paassen, J. Damoiseaux, 2014, American journal of clinical pathology.

Autoantibodies in systemic vasculitis.

J. Tervaert, 1992, Australian and New Zealand journal of medicine.

Levamisole-contaminated cocaine: a hairy affair

E. Pennings, J. Tervaert, T. van der Veer, 2015, BMJ Case Reports.

Commentary Staphylococcus aureus and Wegener ’ s granulomatosis

C. Kallenberg, E. Popa, C. Stegeman, 2015 .

Supplementary Material for: Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy

J. Damoiseaux, J. Tervaert, P. Paassen, 2017 .

Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et al.

C. Kallenberg, C. Stegeman, J. Tervaert, 1994, Arthritis & Rheumatism.

Trimethoprim-sulfamethoxazole monotherapy for active loco- regional or limited Wegener's granulomatosis

C. Stegeman, J. Tervaert, M. Boomsma, 2001 .

Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis

V. Tesar, P. Heinzel, A. Bruchfeld, 2008, Annals of the rheumatic diseases.

Prevention of relapses in antineutrophil cytoplasmic antibody associated vasculitis by treatment based on autoantibody levels as detected by solid phase assay: a preliminary report

C. Kallenberg, P. Limburg, J. Hermans, 2001 .

A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis

P. van Paassen, F. Hiepe, K. Egerer, 2008, Annals of the rheumatic diseases.

Vasculitis and the intensive care.

J. Tervaert, 2007, Acta clinica Belgica.

Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, C. Stegeman, 2001, Journal of immunological methods.

Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis.

J. Tervaert, 2018 .

[Pulmonary hemorrhage with respiratory insufficiency in Henoch- Schoenlein purpura].

J. Zijlstra, T. S. van der Werf, Y. Stienstra, 2000, Nederlands tijdschrift voor geneeskunde.

Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis.

J. Damoiseaux, C. Stegeman, J. Tervaert, 2002, Arthritis and rheumatism.

Association Study on Two Vitamin D Receptor Gene Polymorphisms and Vitamin D Metabolites in Multiple Sclerosis

P. Menheere, J. Damoiseaux, J. Smolders, 2009, Annals of the New York Academy of Sciences.

Chapter 3 Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener ' s granulomatosis

P. Meroni, C. Stegeman, J. Tervaert, 2018 .

Infections in primary vasculitides.

J. Tervaert, 2002, Cleveland Clinic journal of medicine.

Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice

L. Boon, M. Gijbels, A. Duijvestijn, 2013, PloS one.

Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.

J. Tervaert, 2013 .

Pulmonary vasculitis may obscure large cell lung carcinoma. A case report.

J. Ligtenberg, W. Timens, T. S. van der Werf, 2001, Clinical and experimental rheumatology.

Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice

P. Heeringa, M. Gijbels, A. Duijvestijn, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and Other Vasculitides

Javier Martín, Y. Shoenfeld, S. Bombardieri, 2009, Annals of the New York Academy of Sciences.

Evaluation of a New Fluorescent-Enzyme Immuno-Assay for Diagnosis and Follow-up of ANCA-Associated Vasculitis

J. Damoiseaux, C. Stegeman, J. Tervaert, 2005, Journal of Clinical Immunology.

Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis.

C. Kallenberg, M. Bijl, G. Hoffman, 2002, Arthritis and rheumatism.

Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides.

C. Kallenberg, C. Stegeman, J. Tervaert, 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

What to do when you suspect your patient suffers from pulmonary vasculitis

J. Tervaert, Jan Willem Cohen Tervaert, 2013 .

COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey

K. Burns, L. Saxinger, J. Tervaert, 2022, The Journal of Rheumatology.

Is explantation of silicone breast implants useful in patients with complaints?

J. C. Cohen Tervaert, R. R. van der Hulst, J. Tervaert, 2016, Immunologic research.

Immune and inflammatory mechanisms

J. Barratt, E. Masuda, T. Akizawa, 2011 .

IgA-Epidermolysis Bullosa Acquisita Associated with Lyme Borreliosis: A Case Report

P. Steijlen, J. Tervaert, V. Goossens, 2014 .

New treatments of ANCA-associated vasculitis.

C. Kallenberg, J. Tervaert, 2000, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Nasal Carriage of Staphylococcal Infection in Wegener Granulomatosis

C. Stegeman, J. Tervaert, Cecs Kallenberg, 1994, Annals of Internal Medicine.

Antiendothelial cell antibodies in vasculitis and connective tissue disease

J. C. Cohen Tervaert, M. Hamidou, A. Duijvestijn, 2006, Annals of the rheumatic diseases.

Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model

C. Kallenberg, E. Brouwer, J. Weening, 1993, The Journal of experimental medicine.

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

C. Kallenberg, E. Brouwer, J. Weening, 1994, Kidney international.

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

D. Miller, S. Cepok, B. Hemmer, 2009, Neurology.

Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse.

C. Kallenberg, W. Sluiter, C. Kallenberg, 1999, Arthritis and rheumatism.

Chapter 8 Trimethoprim-sulfamethoxazole monotherapy for active loco-regional or limited Wegener ' s granulomatosis

C. Stegeman, J. Tervaert, M. Boomsma, 2017 .

Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.

S. Heymans, J. Staessen, T. Kuznetsova, 2015, International journal of cardiology.

Anti-endothelial cell antibodies in systemic sclerosis

J. Tervaert, J. C. Tervaert, C. Mihai, 2010, Annals of the rheumatic diseases.

Differential B- and T-cell activation in Wegener's granulomatosis.

C. Kallenberg, E. Popa, C. Kallenberg, 1999, The Journal of allergy and clinical immunology.

International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis

A. Vaglio, D. Blockmans, X. Bossuyt, 2020 .

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

C. Kallenberg, J. Savige, D. Blockmans, 2017 .

Suppression of the clinical and cytokine response to endotoxin by RWJ‐67657, a p38 mitogen‐activated protein‐kinase inhibitor, in healthy human volunteers

J. Ligtenberg, J. Zijlstra, J. C. Cohen Tervaert, 2001, Clinical and experimental immunology.

Prevalence of Reduced Bone Mineral Density in Patients with Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis and the Role of Immunosuppressive Therapy: A Cross-Sectional Study

J. C. Cohen Tervaert, C. Stegeman, J. Tervaert, 2002, Osteoporosis International.

Fatigue in patients with ANCA-associated vasculitis: is avacopan the answer?

J. Tervaert, 2023, The Lancet. Rheumatology.

Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?

P. Heeringa, J. Tervaert, 2004, Kidney international.

Genetics of toll like receptor 9 in ANCA associated vasculitides

F. Moosig, J. Epplen, J. C. Cohen Tervaert, 2013, Annals of the rheumatic diseases.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

P. van Paassen, V. Tesar, C. Savage, 2010, The New England journal of medicine.

Randomized clinical trial of extended versus standard azathioprine maintenance therapy in newly diagnosed PR3-ANCA positive vasculitis patients at high-risk for disease relapse

C. Stegeman, J. Tervaert, J. Sanders, 2013 .

Antimyeloperoxidase-associated lung disease. An experimental model.

C. Kallenberg, P. Heeringa, E. Brouwer, 1999, American journal of respiratory and critical care medicine.

Neutrophil myeloperoxidase activity and the influence of two single‐nucleotide promoter polymorphisms

P. Heeringa, J. Tervaert, R. Theunissen, 2003, British journal of haematology.

Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener’s granulomatosis

P. Meroni, C. Stegeman, J. Tervaert, 2002, Clinical and experimental immunology.

Dapsone hypersensitivity syndrome not related to G6PD deficiency

J. Tervaert, K. Schulkes, L. Haas, 2015, BMJ Case Reports.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group

A. Vaglio, G. Emmi, C. Salvarani, 2019, Internal and Emergency Medicine.

Prevalence of Reduced Bone Mineral Density in Patients with Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis and the Role of Immunosuppressive Therapy: A Cross-Sectional Study

C. Stegeman, J. Tervaert, M. Karsijns, 2002, Osteoporosis International.

ANCA Diagnostics in Clinical Practice: New Developments

J. Damoiseaux, J. Tervaert, J. Austen, 2011 .

Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?

P. Heeringa, J. Tervaert, 2003, The Netherlands journal of medicine.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

P. van Paassen, V. Tesar, C. Savage, 2015, Annals of the rheumatic diseases.

The role of myeloperoxidase in the pathogenesis of systemic vasculitis.

P. Heeringa, J. Tervaert, A. Rutgers, 2004, Clinical and experimental rheumatology.

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

C. Kallenberg, J. Damoiseaux, M. Patnaik, 2003, Journal of immunological methods.

Detection and clinical associations of autoantibodies to myeloid granular proteins.

J. Tervaert, 1993, Advances in experimental medicine and biology.

Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis

P. Menheere, J. Damoiseaux, J. Smolders, 2009, Journal of Neuroimmunology.

Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion.

M. Daha, P. Heeringa, W. Buurman, 2007, The American journal of pathology.

Membranoproliferative glomerulonephritis: the times they are a-changin’

J. Tervaert, 2014, Clinical and Experimental Nephrology.